PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, Île-de-France, France emanuela.romano@curie.fr.\', \'INSERM U932, Department of Immunology, PSL Research University, Institut Curie, Paris, Île-de-France, France.\', \'Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.\', \'Faculty of Medicine, University of Zürich, Zürich, Switzerland.\', \'Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.\', \'Department of Medicine, Brigham and Women\'s Hospital, Boston, MA, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'Broad Institute of MIT and Harvard, Cambridge, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00293210.1136/jitc-2021-002932
?:doi
?:hasPublicationType
?:journal
  • Journal for immunotherapy of cancer
is ?:pmid of
?:pmid
?:pmid
  • 34117117
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.798
?:rankingScore_hIndex
  • 26
?:title
  • Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34117117>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34117117>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all